Acquired ribosomopathies in leukemia and solid tumors

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• Diamond-Blackfan anemia (DBA) is a rare inherited bone marrow failure syndrome.
• DBA is caused by mutations in ribosomal protein genes, such as RPS19, leading to haploinsufficiency.
• Ribosomal protein (RP) defects define a class of diseases known as ribosomopathies.

Purpose of the Study:

• To review somatic ribosomopathies associated with solid tumors and leukemia.
• To examine the role of RP gene mutations and expression levels in cancer development and progression.
• To discuss the association between RP expression and patient outcomes in various malignancies.

Main Methods:

• Literature review of studies on ribosomal proteins and cancer.
• Analysis of genetic mutations and expression patterns of RPs in different cancer types.
• Correlation of RP alterations with clinical outcomes in cancer patients.

Main Results:

• RPS19 haploinsufficiency causes DBA.
• Acquired RPS14 haploinsufficiency is linked to 5q- myelodysplastic syndromes.
• Both under- and overexpression of RPs are implicated in various malignancies, including solid tumors and leukemia.

Conclusions:

• Ribosomopathies represent a growing class of diseases linked to genetic defects in ribosomal proteins.
• RP gene mutations and altered expression are significant factors in cancer pathogenesis.
• Understanding RP roles in cancer may offer insights into prognosis and therapeutic strategies.